In this study, the beam characteristics of a Euromechanics add-on MLC that has been installed on a Varian CLINAC 2100 C/D linear accelerator are presented. This was the first installation of 60-leaf PMLC from Euromechanics Company worldwide and all mechanical and dosimetric parameters were measured before clinical use of this kind of MLC. Mechanical tests were executed for different gantry and collimator angles. Leaf position accuracy and leaf gap reproducibility were checked with four different tests. The leaf transmissions, collimator (Sc), phantom (Sp), total (Sc,p) scatter factors, output of the machine, beam profiles for off-axis ratios, central axis depth dose, flatness, symmetry and penumbra have been measured for different field sizes pre and post MLC installation in 6 and 18 MV-mode. To evaluate the effect of new data on clinical plans, different beam setup configurations conformed with MLC and custom blocks were planned on CT images of thorax a CIRS phantom model 002LFC in the same treatment planning system. Leaf position in picket fence test found to be in range between 4.89-5.02 cm instead of nominal 5 cm, however the results of this test with EPIDs image and PIPSpro software showed the higher deviation rather than the results reported from the tests with EBT3 films. The measured data showed that on average Sc,p and Sc were increased 0.22% (P = 0.86) and 0.34% (P = 0.86) for 6 MV and 0.37% (P = 0.84) and 0.42% (P = 0.88) for 18 MV beams for different field sizes, respectively. Good agreement was observed between the PDD and profile curves pre and post MLC installation that was expected based on no changes in beam energy and geometry of the collimators. Based on the mechanical and dosimetry results which have been achieved from our different standard tests, it was found no significant differences between pre and post MLC installation values. This indicates, installation and using this system is clinically acceptable.

Download full-text PDF

Source
http://dx.doi.org/10.1088/2057-1976/abbd23DOI Listing

Publication Analysis

Top Keywords

pre post
12
post mlc
12
mlc installation
12
euromechanics add-on
8
leaf position
8
field sizes
8
mlc
6
installation
5
commissioning quality
4
quality assurance
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Columbia University, New York, NY, USA.

Background: Focused ultrasound (FUS)-induced blood-brain barrier opening (BBBO) is a technique for safely, non-invasively, and transiently opening the blood brain barrier in a targeted area of the brain. Pre-clinical and clinical studies have shown that FUS is capable of decreasing amyloid plaque load and stimulating neurogenesis in Alzheimer's Disease (AD) models, in addition to being safe for use in human patients. However, the effect of FUS-BBBO on neurons has not yet been characterized, despite its crucial role in cognition and regulating brain function.

View Article and Find Full Text PDF

Background: Epidemiological studies report an elevated risk of neurodegenerative disorders, particularly Parkinson's disease (PD), in patients with type 2 diabetes mellitus (T2DM) that is mitigated in those prescribed incretin mimetics or dipeptidyl peptidase 4 inhibitors (DPP-4Is). Incretin mimetic repurposing appears promising in human PD and Alzheimer's disease (AD) clinical trials. DPP-4Is are yet to be evaluated in PD or AD human studies.

View Article and Find Full Text PDF

Background: Understanding the fundamental differences between the human and pre-human brain is a prerequisite for designing meaningful models and therapies for AD. Expressed CHRFAM7A, a human restricted gene with carrier frequency of 75% in the human population predicts profound translational significance.

Method: The physiological role of CHRFAM7A in human brain is explored using multiomics approach on 600 post mortem human brain tissue samples (ROSMAP).

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Olabisi Onabanjo University, Sagamu, Ogun, Nigeria.

Background: Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid beta proteins to form plaques and the aggregation of hyperphosphorylated tau to form neurofibrillary tangles. Human fibroblast (SH-SY5Y) cells endogenously express Tau, and the expression is further amplified upon differentiation into neuronal cells, making it a cell model of Alzheimer's disease. Nigella sativa oil (NSO) contains 50% thymoquinone and has been used in the treatment of various nervous system disorders.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Vanderbilt University Medical Center, Nashville, TN, USA.

Background: We report the case of a 79-year-old woman with Alzheimer's disease who enrolled in a clinical study of lecanemab. After the third, biweekly infusion she suffered a seizure followed by aphasia and progressive encephalopathy. Magnetic resonance imaging revealed multifocal cerebral edema and an increased burden of cerebral microhemorrhages compared to pre-trial imaging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!